United States Biotechnology & Medical Research

MoonLake Immunotherapeutics (MLTX)

Track

Track

MoonLake Immunotherapeutics experienced fifteen insider trading transactions over the past ninety days, all involving sales totaling approximately 14.3 million dollars. Key executives, including the CEO, CFO, and CSO, offloaded shares through planned divestments. This activity follows a period where the stock price declined significantly, despite a recent positive earnings report.
Ticker: MLTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MoonLake Immunotherapeutics. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
77.17
Quantity 30,680 +14.6%
Value US$1,190,542
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
360.33
Quantity 86,907 +21.3%
Value US$1,401,821
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
56.08
Quantity 31,373 -45.6%
Value US$2,509,189
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.09
Quantity 43,700 -1.6%
Value US$877,933
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.01
Quantity 16,105 -0.6%
Value US$322,261
1.8
Reich Kristian Officer Officer
Transaction date
Proposed sale
Price
19.44
Quantity 150,000
Value US$2,916,000
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.02
Quantity 68,289 -2.4%
Value US$1,367,146
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.01
Quantity 33,936 -1.2%
Value US$679,059
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.03
Quantity 47,775 -1.6%
Value US$956,933
2.2
Santos da Silva Jorge Officer; CEO Officer
Transaction date
Proposed sale
Price
20.03
Quantity 150,000
Value US$3,004,500
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
22.04
Quantity 39,120 -3.4%
Value US$862,205
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.60
Quantity 2,794 -0.2%
Value US$54,762
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.68
Quantity 15,082 -1.3%
Value US$296,814
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.43
Quantity 50,000 -1.7%
Value US$971,500
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.70
Quantity 50,000 -1.7%
Value US$935,000
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.89
Quantity 50,000 -1.7%
Value US$944,500
1.8
Reich Kristian Officer Officer
Transaction date
Proposed sale
Price
19.00
Quantity 150,000
Value US$2,850,000
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.02
Quantity 13,653 -1.2%
Value US$273,333
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.56
Quantity 2,426 -0.2%
Value US$47,453
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Sale
Price
18.23
Quantity 51,873 -1.7%
Value US$945,645
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Sale
Price
18.41
Quantity 98,127 -3.2%
Value US$1,806,518
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.51
Quantity 1,925 -0.2%
Value US$37,557
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.94
Quantity 85,870 -6.7%
Value US$1,626,378
3.2
Bodenstedt Matthias Officer; CFO Officer
Transaction date
Proposed sale
Price
18.46
Quantity 160,870
Value US$2,969,660
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.79
Quantity 248,530 -19.3%
Value US$4,172,819
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.79
Quantity 1,569,116 -19.2%
Value US$26,345,458
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.79
Quantity 1,932,354 -18.9%
Value US$32,444,224
4.0
BVF PARTNERS L P/IL 10% Stockholder; Affiliate of Director Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
16.93
Quantity 3,750,000
Value US$63,487,500
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.49
Quantity 70,000 -2.4%
Value US$1,014,300
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Sale
Price
14.43
Quantity 72,908 -100.0%
Value US$1,052,062
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.08
Quantity 130,000 -4.2%
Value US$1,960,400
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Sale
Price
15.08
Quantity 130,000 -64.1%
Value US$1,960,400
2.2
Jorge Pedro Santos Radeck Da Silva Officer; Director; CEO Executive Director
Transaction date
Proposed sale
Price
14.90
Quantity 200,000
Value US$2,980,000
1.8
Kristian Dieter Johannes Reich Officer; Director; Chief Scientific Officer Executive Director
Transaction date
Proposed sale
Price
14.80
Quantity 202,908
Value US$3,003,038
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Purchase
Price
9.09
Quantity 10,870 +1.8%
Value US$98,808
2.2
Chen Bihua Former 10% Owner
Transaction date
Sale
Price
6.96
Quantity 5,827 -0.3%
Value US$40,556
2.2
Chen Bihua Former 10% Owner
Transaction date
Sale
Price
6.61
Quantity 2,800,000 -58.3%
Value US$18,508,000
2.2
Chen Bihua Former 10% Owner
Transaction date
Sale
Price
7.58
Quantity 3,390,943 -41.4%
Value US$25,703,348
2.2
Chen Bihua Former 10% Owner
Transaction date
Sale
Price
8.40
Quantity 232,460 -2.8%
Value US$1,952,664
2.2
Chen Bihua Former 10% Owner
Transaction date
Sale
Price
9.38
Quantity 70,748 -0.8%
Value US$663,616
3.6
Moukheibir Catherine Non-Executive Director
Transaction date
Sale
Price
48.79
Quantity 23,500 -100.0%
Value US$1,146,565
3.6
Moukheibir Catherine Director Non-Executive Director
Transaction date
Proposed sale
Price
48.79
Quantity 23,500
Value US$1,146,595
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
50.00
Quantity 132,549 -9.3%
Value US$6,627,662
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
50.00
Quantity 836,862 -9.3%
Value US$41,844,439
4.0
BVF PARTNERS L P/IL Non-Executive Director Large shareholder
Transaction date
Sale
Price
50.00
Quantity 1,030,589 -9.1%
Value US$51,531,099
2.9
Sturge Simon Non-Executive Director
Transaction date
Sale
Price
53.72
Quantity 171,000 -49.9%
Value US$9,186,120
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
55.89
Quantity 4,740 -0.2%
Value US$264,919
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.00
Quantity 28,090 -40.1%
Value US$1,544,950
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.00
Quantity 31,910 -1.1%
Value US$1,755,050
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
55.00
Quantity 56,065 -1.8%
Value US$3,083,575
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.00
Quantity 29,431 -29.6%
Value US$1,618,705
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.00
Quantity 29,491 -1.0%
Value US$1,622,005
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
55.00
Quantity 62,810 -2.0%
Value US$3,454,550
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
55.27
Quantity 1,125 -0.0%
Value US$62,179
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.30
Quantity 569 -0.6%
Value US$31,466
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.31
Quantity 509 -0.0%
Value US$28,153
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
57.43
Quantity 10,000 -9.1%
Value US$574,300
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
57.45
Quantity 10,000 -0.3%
Value US$574,500
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
57.44
Quantity 20,000 -0.6%
Value US$1,148,800
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
60.15
Quantity 20,000 -0.6%
Value US$1,203,000
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
60.15
Quantity 10,000 -8.3%
Value US$601,500
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
60.15
Quantity 10,000 -0.3%
Value US$601,500
2.2
Santos da Silva Jorge Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
60.18
Quantity 20,000 -0.6%
Value US$1,203,600
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
60.16
Quantity 10,000 -7.7%
Value US$601,600
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
60.17
Quantity 10,000 -0.3%
Value US$601,700
2.2
Santos da Silva Jorge CEO
Transaction date
Proposed sale
Price
63.95
Quantity 200,000
Value US$12,790,000
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
62.43
Quantity 10,000 -7.1%
Value US$624,300
1.8
Reich Kristian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
62.42
Quantity 10,000 -0.3%
Value US$624,200
1.8
Reich Kristian Officer; CSO Officer
Transaction date
Proposed sale
Price
63.01
Quantity 200,000
Value US$12,602,000
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
58.34
Quantity 5,264 -1.0%
Value US$307,102
3.2
Bodenstedt Matthias Officer; CFO Officer
Transaction date
Proposed sale
Price
59.27
Quantity 5,264
Value US$311,997
3.2
Bodenstedt Matthias Chief Financial Officer Officer
Transaction date
Planned sale
Price
59.22
Quantity 94,736 -15.3%
Value US$5,610,266
3.2
Bodenstedt Matthias Officer; CFO Officer
Transaction date
Proposed sale
Price
59.22
Quantity 94,736
Value US$5,610,266
2.2
Chen Bihua Large shareholder
Transaction date
Purchase
Price
59.90
Quantity 58,839 +0.7%
Value US$3,524,297
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
30,680 +14.6%
77.17
US$1,190,542 		30,680 +14.6% 77.17 US$1,190,542
2026-07-23 2026-07-22 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
86,907 +21.3%
360.33
US$1,401,821 		86,907 +21.3% 360.33 US$1,401,821
2026-07-23 2026-07-21 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
31,373 -45.6%
56.08
US$2,509,189 		31,373 -45.6% 56.08 US$2,509,189
2026-07-21 2026-07-20 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
43,700 -1.6%
20.09
US$877,933 		43,700 -1.6% 20.09 US$877,933
2026-07-20 2026-07-15 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
16,105 -0.6%
20.01
US$322,261 		16,105 -0.6% 20.01 US$322,261
2026-07-15 2026-07-15 PrS Proposed sale
1.8
Reich Kristian

Officer

Officer
150,000
19.44
US$2,916,000 		150,000 19.44 US$2,916,000
2026-07-13 2026-07-10 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
68,289 -2.4%
20.02
US$1,367,146 		68,289 -2.4% 20.02 US$1,367,146
2026-07-13 2026-07-09 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
33,936 -1.2%
20.01
US$679,059 		33,936 -1.2% 20.01 US$679,059
2026-07-02 2026-07-01 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
47,775 -1.6%
20.03
US$956,933 		47,775 -1.6% 20.03 US$956,933
2026-06-30 2026-06-30 PrS Proposed sale
2.2
Santos da Silva Jorge

Officer; CEO

Officer
150,000
20.03
US$3,004,500 		150,000 20.03 US$3,004,500
2026-06-23 2026-06-22 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
39,120 -3.4%
22.04
US$862,205 		39,120 -3.4% 22.04 US$862,205
2026-06-18 2026-06-18 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
2,794 -0.2%
19.60
US$54,762 		2,794 -0.2% 19.60 US$54,762
2026-06-18 2026-06-17 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
15,082 -1.3%
19.68
US$296,814 		15,082 -1.3% 19.68 US$296,814
2026-06-17 2026-06-17 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
50,000 -1.7%
19.43
US$971,500 		50,000 -1.7% 19.43 US$971,500
2026-06-17 2026-06-16 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
50,000 -1.7%
18.70
US$935,000 		50,000 -1.7% 18.70 US$935,000
2026-06-17 2026-06-15 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
50,000 -1.7%
18.89
US$944,500 		50,000 -1.7% 18.89 US$944,500
2026-06-15 2026-06-15 PrS Proposed sale
1.8
Reich Kristian

Officer

Officer
150,000
19.00
US$2,850,000 		150,000 19.00 US$2,850,000
2026-05-13 2026-05-11 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
13,653 -1.2%
20.02
US$273,333 		13,653 -1.2% 20.02 US$273,333
2026-04-16 2026-04-14 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
2,426 -0.2%
19.56
US$47,453 		2,426 -0.2% 19.56 US$47,453
2026-04-14 2026-04-13 S Sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
51,873 -1.7%
18.23
US$945,645 		51,873 -1.7% 18.23 US$945,645
2026-04-14 2026-04-10 S Sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
98,127 -3.2%
18.41
US$1,806,518 		98,127 -3.2% 18.41 US$1,806,518
2026-04-10 2026-04-10 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
1,925 -0.2%
19.51
US$37,557 		1,925 -0.2% 19.51 US$37,557
2026-04-10 2026-04-10 PrS Proposed sale
2.2
Jorge Pedro Santos Radeck D Silva

CEO
150,000
18.58
US$2,787,000 		150,000 18.58 US$2,787,000
2026-04-10 2026-04-09 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
85,870 -6.7%
18.94
US$1,626,378 		85,870 -6.7% 18.94 US$1,626,378
2026-04-09 2026-04-09 PrS Proposed sale
3.2
Bodenstedt Matthias

Officer; CFO

Officer
160,870
18.46
US$2,969,660 		160,870 18.46 US$2,969,660
2026-04-02 2026-03-31 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
248,530 -19.3%
16.79
US$4,172,819 		248,530 -19.3% 16.79 US$4,172,819
2026-04-02 2026-03-31 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
1,569,116 -19.2%
16.79
US$26,345,458 		1,569,116 -19.2% 16.79 US$26,345,458
2026-04-02 2026-03-31 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
1,932,354 -18.9%
16.79
US$32,444,224 		1,932,354 -18.9% 16.79 US$32,444,224
2026-03-31 2026-03-31 PrS Proposed sale
4.0
BVF PARTNERS L P/IL

10% Stockholder; Affiliate of Director

Non-Executive Director Large shareholder
3,750,000
16.93
US$63,487,500 		3,750,000 16.93 US$63,487,500
2025-12-10 2025-12-09 S Sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
70,000 -2.4%
14.49
US$1,014,300 		70,000 -2.4% 14.49 US$1,014,300
2025-12-10 2025-12-09 S Sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
72,908 -100.0%
14.43
US$1,052,062 		72,908 -100.0% 14.43 US$1,052,062
2025-12-10 2025-12-08 S Sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
130,000 -4.2%
15.08
US$1,960,400 		130,000 -4.2% 15.08 US$1,960,400
2025-12-10 2025-12-08 S Sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
130,000 -64.1%
15.08
US$1,960,400 		130,000 -64.1% 15.08 US$1,960,400
2025-12-08 2025-12-08 PrS Proposed sale
2.2
Jorge Pedro Santos Radeck Da Silva

Officer; Director; CEO

Executive Director
200,000
14.90
US$2,980,000 		200,000 14.90 US$2,980,000
2025-12-08 2025-12-08 PrS Proposed sale
1.8
Kristian Dieter Johannes Reich

Officer; Director; Chief Scientific Officer

Executive Director
202,908
14.80
US$3,003,038 		202,908 14.80 US$3,003,038
2025-10-09 2025-10-08 B Purchase
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
10,870 +1.8%
9.09
US$98,808 		10,870 +1.8% 9.09 US$98,808
2025-10-01 2025-09-30 S Sale
2.2
Chen Bihua

Former 10% Owner
5,827 -0.3%
6.96
US$40,556 		5,827 -0.3% 6.96 US$40,556
2025-10-01 2025-09-29 S Sale
2.2
Chen Bihua

Former 10% Owner
2,800,000 -58.3%
6.61
US$18,508,000 		2,800,000 -58.3% 6.61 US$18,508,000
2025-10-01 2025-09-29 S Sale
2.2
Chen Bihua

Former 10% Owner
3,390,943 -41.4%
7.58
US$25,703,348 		3,390,943 -41.4% 7.58 US$25,703,348
2025-10-01 2025-09-29 S Sale
2.2
Chen Bihua

Former 10% Owner
232,460 -2.8%
8.40
US$1,952,664 		232,460 -2.8% 8.40 US$1,952,664
2025-10-01 2025-09-29 S Sale
2.2
Chen Bihua

Former 10% Owner
70,748 -0.8%
9.38
US$663,616 		70,748 -0.8% 9.38 US$663,616
2025-07-07 2025-07-03 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
23,500 -100.0%
48.79
US$1,146,565 		23,500 -100.0% 48.79 US$1,146,565
2025-07-03 2025-07-03 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
23,500
48.79
US$1,146,595 		23,500 48.79 US$1,146,595
2024-10-08 2024-10-04 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
132,549 -9.3%
50.00
US$6,627,662 		132,549 -9.3% 50.00 US$6,627,662
2024-10-08 2024-10-04 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
836,862 -9.3%
50.00
US$41,844,439 		836,862 -9.3% 50.00 US$41,844,439
2024-10-08 2024-10-04 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
1,030,589 -9.1%
50.00
US$51,531,099 		1,030,589 -9.1% 50.00 US$51,531,099
2024-10-08 2024-10-04 S Sale
2.9
Sturge Simon
Non-Executive Director
171,000 -49.9%
53.72
US$9,186,120 		171,000 -49.9% 53.72 US$9,186,120
2024-02-29 2024-02-29 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
4,740 -0.2%
55.89
US$264,919 		4,740 -0.2% 55.89 US$264,919
2024-02-29 2024-02-28 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
28,090 -40.1%
55.00
US$1,544,950 		28,090 -40.1% 55.00 US$1,544,950
2024-02-29 2024-02-28 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
31,910 -1.1%
55.00
US$1,755,050 		31,910 -1.1% 55.00 US$1,755,050
2024-02-29 2024-02-28 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
56,065 -1.8%
55.00
US$3,083,575 		56,065 -1.8% 55.00 US$3,083,575
2024-02-29 2024-02-27 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
29,431 -29.6%
55.00
US$1,618,705 		29,431 -29.6% 55.00 US$1,618,705
2024-02-29 2024-02-27 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
29,491 -1.0%
55.00
US$1,622,005 		29,491 -1.0% 55.00 US$1,622,005
2024-02-29 2024-02-27 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
62,810 -2.0%
55.00
US$3,454,550 		62,810 -2.0% 55.00 US$3,454,550
2024-02-23 2024-02-21 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
1,125 -0.0%
55.27
US$62,179 		1,125 -0.0% 55.27 US$62,179
2024-02-22 2024-02-21 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
569 -0.6%
55.30
US$31,466 		569 -0.6% 55.30 US$31,466
2024-02-22 2024-02-21 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
509 -0.0%
55.31
US$28,153 		509 -0.0% 55.31 US$28,153
2024-02-22 2024-02-20 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -9.1%
57.43
US$574,300 		10,000 -9.1% 57.43 US$574,300
2024-02-22 2024-02-20 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
57.45
US$574,500 		10,000 -0.3% 57.45 US$574,500
2024-02-20 2024-02-20 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
20,000 -0.6%
57.44
US$1,148,800 		20,000 -0.6% 57.44 US$1,148,800
2024-02-20 2024-02-16 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
20,000 -0.6%
60.15
US$1,203,000 		20,000 -0.6% 60.15 US$1,203,000
2024-02-16 2024-02-16 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -8.3%
60.15
US$601,500 		10,000 -8.3% 60.15 US$601,500
2024-02-16 2024-02-16 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
60.15
US$601,500 		10,000 -0.3% 60.15 US$601,500
2024-02-20 2024-02-15 PlS Planned sale
2.2
Santos da Silva Jorge

Chief Executive Officer

Executive Director
20,000 -0.6%
60.18
US$1,203,600 		20,000 -0.6% 60.18 US$1,203,600
2024-02-16 2024-02-15 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -7.7%
60.16
US$601,600 		10,000 -7.7% 60.16 US$601,600
2024-02-16 2024-02-15 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
60.17
US$601,700 		10,000 -0.3% 60.17 US$601,700
2024-02-15 2024-02-15 PrS Proposed sale
2.2
Santos da Silva Jorge

CEO
200,000
63.95
US$12,790,000 		200,000 63.95 US$12,790,000
2024-02-16 2024-02-14 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -7.1%
62.43
US$624,300 		10,000 -7.1% 62.43 US$624,300
2024-02-16 2024-02-14 PlS Planned sale
1.8
Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
62.42
US$624,200 		10,000 -0.3% 62.42 US$624,200
2024-02-14 2024-02-14 PrS Proposed sale
1.8
Reich Kristian

Officer; CSO

Officer
200,000
63.01
US$12,602,000 		200,000 63.01 US$12,602,000
2023-12-21 2023-12-20 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
5,264 -1.0%
58.34
US$307,102 		5,264 -1.0% 58.34 US$307,102
2023-12-20 2023-12-20 PrS Proposed sale
3.2
Bodenstedt Matthias

Officer; CFO

Officer
5,264
59.27
US$311,997 		5,264 59.27 US$311,997
2023-12-21 2023-12-19 PlS Planned sale
3.2
Bodenstedt Matthias

Chief Financial Officer

Officer
94,736 -15.3%
59.22
US$5,610,266 		94,736 -15.3% 59.22 US$5,610,266
2023-12-19 2023-12-19 PrS Proposed sale
3.2
Bodenstedt Matthias

Officer; CFO

Officer
94,736
59.22
US$5,610,266 		94,736 59.22 US$5,610,266
2023-10-10 2023-10-05 B Purchase
2.2
Chen Bihua
Large shareholder
58,839 +0.7%
59.90
US$3,524,297 		58,839 +0.7% 59.90 US$3,524,297
Explore more

More insider trading research around MoonLake Immunotherapeutics

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America